Recommendations for contraception in clinical trials

The recommendations guide sponsors/investigators concerning which methods of contraception are considered efficient enough to avoid pregnancy in fertile women participating in clinical trials. The document also describes risk mitigation for fertile women and men included in clinical trials.

The recommendations may be be found on the HMA web site, under Key documents list.